Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microcap Report: Theralase Tech. (V.TLT), Sirona Biochem (V.SBM), Xmet (V.XME) active

Stockhouse Editorial
0 Comments| May 29, 2014

{{labelSign}}  Favorites
{{errorMessage}}

Theralase Technologies Inc. (TSX:V.TLT, Stock Forum) jumped 64% to 41 cents Thursday after the Toronto-based company said results from pre-clinical trials carried out at Princess Margaret Cancer Centre, University Health Network, regarding its flagship Photo Dynamic Compound (PDC).

Theralase is a designer, developer, manufacturer and marketer of patented super-pulsed laser technologies

According to the news release, the PDC was intended for the destruction of cancer, but also demonstrated the ability to render animals immune to repeated exposures of the same cancer.

Sirona Biochem Corp. (TSX: V.SBM, Stock Forum) rose 15% to 11.5 cents. The Vancouver-based cosmetic ingredient and drug discovery firm, announced Thursday that the company expanded its exclusive license with Valeant Pharmaceuticals International Inc. (TSX: T.VRX, Stock Forum) for the company’s skin lightening compound TFC-849 to include AMBI and Kinerase.

According to a news release,the license gives Valeant exclusive global rights to TFC-849.

Xmet Inc. (TSX: V.XME, Stock Forum) was off 57% to 3 cents after the company released a comprehensive update on its Blackflake East and West projects near Hearst, Ontario.

For details, see the company’s press release. The Blackfalke project comprises over 29,000 acres of 100%-owned claims and 7,000 acres of optioned claims, approximately 60 kilometres to the northeast of Hearst.

Select Canadian Small/Micro-cap Advancers (as of 4:00 PM Eastern)
Theralase Technologies Inc. (V.TLT, Stock Forum) 64.00%
Trimel Pharmaceuticals Corporation (T.TRL, Stock Forum) 22.54%
Caza Oil & Gas, Inc. (T.CAZ, Stock Forum) 16.67%
Sirona Biochem Corp. (V.SBM, Stock Forum) 15.00%
Espial Group Inc. (T.ESP, Stock Forum) 14.58%
Select Canadian Small/Micro-cap Decliners (as of 4:00 PM Eastern)
Xmet Inc. (V.XME, Stock Forum) -57.14%
Ecuador Gold and Copper Corp. (V.EGX, Stock Forum) -36.36%
Africa Hydrocarbons Inc. (V.NFK, Stock Forum) -28.57%
Macro Enterprises Inc. (V.MCR, Stock Forum) -21.67%
DualEx Energy International Inc. (V.DXE, Stock Forum) -21.43%


{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.